Holen Sie sich die Stockscreener-App
68.57
2.22%
1.49
Handel nachbörslich:
68.57
Mbx Biosciences Inc Aktie (MBX) Neueste Nachrichten
California State Teachers Retirement System Purchases 21,011 Shares of MBX Biosciences, Inc. $MBX - marketbeat.com
Deep Track Capital reports 3.64% MBX Biosciences (MBX) stake in 13G/A - Stock Titan
Stifel Maintains MBX Biosciences(MBX.US) With Buy Rating, Raises Target Price to $70 - moomoo.com
MBX Biosciences (MBX) Short Interest & Short Float | Updated Aug 2026 - marketbeat.com
Frazier funds detail 10.8% MBX Biosciences stake (MBX) in ownership update - Stock Titan
OrbiMed trims MBX Biosciences (MBX) position to 6.4% after share sales - Stock Titan
Truist Adjusts Price Target on MBX Biosciences to $88 From $70, Maintains Buy Rating - moomoo.com
MBX Biosciences, Inc. $MBX Stock Holdings Raised by The Manufacturers Life Insurance Company - marketbeat.com
LifeSci Capital Maintains MBX Biosciences(MBX.US) With Buy Rating, Maintains Target Price $121 - moomoo.com
MBX Biosciences (NASDAQ:MBX) Lowered to "Sell" Rating by Wall Street Zen - marketbeat.com
Mizuho Securities Maintains MBX Biosciences(MBX.US) With Buy Rating, Maintains Target Price $91 - Moomoo
MBX SWOT Analysis: Financial Challenges and Growth Potential Rev - GuruFocus
Barclays Maintains MBX Biosciences(MBX.US) With Buy Rating, Raises Target Price to $88 - moomoo.com
MBX Biosciences (MBX) Stock Analysis: Strong Buy Ratings and Significant Upside Potential - DirectorsTalk Interviews
MBX Biosciences, Inc. Stock 12‑Month Price Target Raised to $84.8, Implies 26% Upside - TradingView
MBX Biosciences Shares Lower After Q2 Loss Widens - marketscreener.com
MBX Biosciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com
MBX Biosciences, Inc. reports results for the quarter ended June 30Earnings Summary - TradingView
Earnings Flash (MBX) MBX Biosciences Posts Q2 Net Loss $0.78 a Share, vs. FactSet Est of $0.63 Loss - marketscreener.com
MBX Biosciences posts Q2 loss, advances obesity pipeline By Investing.com - Investing.com South Africa
MBX Biosciences posts Q2 loss, advances obesity pipeline - Investing.com
MBX Biosciences Reports Second Quarter 2026 Financial Results and Corporate Highlights - The Manila Times
MBX Biosciences posts $37.1 million Q2 net loss - Quiver Quantitative
Earnings Flash (MBX) MBX Biosciences Posts Q2 Net Loss $0.78 a Share, Vs. FactSet Est of $0.63 Loss - Moomoo
MBX Biosciences 2Q 2026: Net loss $(37.1M), EPS $(0.78) — 10-Q Summary - TradingView
MBX: Q2 net loss increased to $37.1M as R&D spending rose; cash reserves support operations into 2029 - TradingView
MBX Biosciences (Nasdaq: MBX) widens Q2 loss but holds $418.6M cash - Stock Titan
MBX Biosciences (MBX) Earnings Date and Reports 2026 - marketbeat.com
Insider Selling: MBX Biosciences (NASDAQ:MBX) Insider Sells $24,334.90 in Stock - MarketBeat
MBX Biosciences (MBX) CMO sells 370 shares to cover RSU taxes - Stock Titan
MBX: Advancing precision peptide therapies for endocrine and obesity indications with strong clinical momentum - TradingView
MBX Q2'26 Earnings: EPS estimate is (0.63) USD - TradingView
MBX Biosciences (NASDAQ:MBX) Reaches New 52-Week HighStill a Buy? - marketbeat.com
Mbx Biosciences stock hits all-time high of 69.5 USD By Investing.com - Investing.com India
MBX (MBX) affiliate plans to sell 936 vested common shares after prior sale - Stock Titan
Salomon Azoulay plans 370-share sale of MBX (NASDAQ: MBX) - Stock Titan
Mbx Biosciences stock hits all-time high of 69.5 USD - Investing.com
MBX Biosciences, Inc. (MBX) awards CFO 130,000 options and 28,000 RSUs - Stock Titan
MBX Biosciences, Inc. (MBX) grants CEO major option and RSU awards - Stock Titan
Swiss National Bank Invests $1.32 Million in MBX Biosciences, Inc. $MBX - marketbeat.com
MBX Biosciences, Inc. $MBX Shares Purchased by Stempoint Capital LP - MarketBeat
MBX Biosciences (NASDAQ:MBX) Sets New 52-Week High on Analyst Upgrade - marketbeat.com
MBX Biosciences | SCHEDULE 13G: Others - moomoo.com
EcoR1 Capital LLC Decreases Stock Position in MBX Biosciences, Inc. $MBX - MarketBeat
Wall Street Zen Upgrades MBX Biosciences (NASDAQ:MBX) to Hold - marketbeat.com
MBX Biosciences Inc (MBX) Financial Health: Profitability & Balance Sheet Analysis - TradingKey
MBX Biosciences Inc (MBX) Institutional Confidence - TradingKey
MBX Biosciences, Inc. $MBX is Orbimed Advisors LLC's 10th Largest Position - MarketBeat
MBX Biosciences Inc (MBX) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey
MBX Biosciences Market Sentiment - Benzinga España
MBX Biosciences Inc (MBX) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
MBX Biosciences Inc (MBX) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
MBX Biosciences, Inc. Revenue Breakdown – NASDAQ:MBX - TradingView
MBX Biosciences Inc (MBX) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
MBX|MBX Biosciences Inc|Price:61.267|Chg%:-0.733 - TradingKey
MBX|MBX Biosciences Inc|Price:62.000|Chg%:-1.570 - TradingKey
TradingKey - TradingKey
MBX|MBX Biosciences Inc|Price:66.990|Chg%:+0.020 - TradingKey
MBX Biosciences Inc (MBX) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
Affinity Asset Advisors LLC Reduces Holdings in MBX Biosciences, Inc. $MBX - MarketBeat
MBX Biosciences stock hits all-time high at 66.66 USD By Investing.com - Investing.com India
0.52%
0.07%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):